Ole Andreas Halvorsen - Viking Global Investors 13F Activity & Position Changes (Q3 2022)
As of Sep 30, 2022, the Viking Global Investors portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Nov 14, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q3 2022, the filing reported:
New Buys - Apellis Pharmaceuticals, Inc., Alibaba Group Holding Limited, CBRE Group Inc, Cadence Design Systems, Inc., Clorox Company (The), and 14 more
Increases - Ameriprise Financial, Inc., Amazon.com, Inc., APi Group Corporation, Brookfield Asset Management Ltd., BioMarin Pharmaceutical Inc., and 22 more
Reductions - Acadia Healthcare Company, Inc., Amylyx Pharmaceuticals, Inc., Avantor, Inc., KE Holdings Inc, Chubb Limited, and 18 more
Complete Exits - American International Group, I, Aon Plc, Boeing Company (The), Booking Holdings Inc. Common St, Avis Budget Group, Inc., and 8 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q3 2022
|
ACHC
Acadia Healthcare Company, Inc.
|
Sell |
-519,544
|
|
Q3 2022
|
AIG
American International Group, I
|
Sell - Position Exit |
-10,108,715
|
|
Q3 2022
|
AMLX
Amylyx Pharmaceuticals, Inc.
|
Sell |
-1,400,000
|
|
Q3 2022
|
AMP
Ameriprise Financial, Inc.
|
Buy |
+620,093
|
|
Q3 2022
|
AMZN
Amazon.com, Inc.
|
Buy |
+1,182,054
|
|
Q3 2022
|
AON
Aon Plc
|
Sell - Position Exit |
-704,639
|
|
Q3 2022
|
APG
APi Group Corporation
|
Buy |
+184,754
|
|
Q3 2022
|
APLS
Apellis Pharmaceuticals, Inc.
|
Buy - Position Entry |
+932,441
|
|
Q3 2022
|
AVTR
Avantor, Inc.
|
Sell |
-3,270,023
|
|
Q3 2022
|
BA
Boeing Company (The)
|
Sell - Position Exit |
-1,391,238
|
|
Q3 2022
|
BABA
Alibaba Group Holding Limited
|
Buy - Position Entry |
+1,246,400
|
|
Q3 2022
|
BAM
Brookfield Asset Management Ltd.
|
Buy |
+2,625,832
|
|
Q3 2022
|
BEKE
KE Holdings Inc
|
Sell |
-6,515,507
|
|
Q3 2022
|
BKNG
Booking Holdings Inc. Common St
|
Sell - Position Exit |
-89,251
|
|
Q3 2022
|
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
+46,571
|
|
Q3 2022
|
BSX
Boston Scientific Corporation
|
Buy |
+1,508,967
|
|
Q3 2022
|
CAR
Avis Budget Group, Inc.
|
Sell - Position Exit |
-278,673
|
|
Q3 2022
|
CB
Chubb Limited
|
Sell |
-180,984
|
|
Q3 2022
|
CBRE
CBRE Group Inc
|
Buy - Position Entry |
+409,714
|
|
Q3 2022
|
CDNS
Cadence Design Systems, Inc.
|
Buy - Position Entry |
+605,539
|
|
Q3 2022
|
CLDX
Celldex Therapeutics, Inc.
|
Sell - Position Exit |
-2,337,854
|
|
Q3 2022
|
CLX
Clorox Company (The)
|
Buy - Position Entry |
+606,655
|
|
Q3 2022
|
CME
CME Group Inc.
|
Buy |
+322,471
|
|
Q3 2022
|
CNC
Centene Corporation
|
Sell - Position Exit |
-8,293,867
|
|
Q3 2022
|
CRL
Charles River Laboratories Inte
|
Buy |
+105,069
|
|
Q3 2022
|
CRM
Salesforce, Inc.
|
Buy - Position Entry |
+2,400,649
|
|
Q3 2022
|
CRWD
CrowdStrike Holdings, Inc.
|
Buy - Position Entry |
+284,329
|
|
Q3 2022
|
CTLT
Catalent, Inc.
|
Sell |
-287,494
|
|
Q3 2022
|
DAWN
Day One Biopharmaceuticals, Inc
|
Sell |
-298,861
|
|
Q3 2022
|
DG
Dollar General Corporation
|
Buy |
+1,316,194
|
Page 1 of 3